Rex Haydon to Thiazolidinediones
This is a "connection" page, showing publications Rex Haydon has written about Thiazolidinediones.
Connection Strength
0.217
-
Nuclear receptor agonists as potential differentiation therapy agents for human osteosarcoma. Clin Cancer Res. 2002 May; 8(5):1288-94.
Score: 0.182
-
A blockade of PI3K? signaling effectively mitigates angiotensin II-induced renal injury and fibrosis in a mouse model. Sci Rep. 2018 Jul 20; 8(1):10988.
Score: 0.035